California Pharmacy Law Exam · Topics · Exam guide · Sample questions
Practice questions written by us, with the correct answer and the rule cited. They are not official questions.
1. Under Business and Professions Code section 4052(a), which function related to laboratory tests is within a pharmacist's authority?
Business and Professions Code section 4052(a)(11) authorizes a pharmacist to “Order and interpret tests”. Section 4052(a) grants no diagnosing authority, since the preventative services in paragraph (10) are those that do not require a diagnosis, and the laboratory license is issued by the state under the section 1265 reference in section 4052.4(b)(2), not by the pharmacist.
2. On a patient-centered label under 16 CCR section 1707.5, which item is listed immediately after the name of the patient in the clustered area?
16 CCR section 1707.5(a)(1) clusters four items in a set order: patient name, then drug name and strength, then directions for use, then condition or purpose. Directions and condition or purpose come later in that order. The quantity dispensed is one of the remaining elements of Business and Professions Code section 4076, which section 1707.5(a)(3) places outside the clustered area.
3. Under 16 CCR section 1746.1, for which request must the pharmacist measure and record the patient's seated blood pressure?
16 CCR section 1746.1(b)(4)(C) requires the pharmacist to measure and record the seated blood pressure “if combined hormonal contraceptives are requested or recommended”. A pill with a progestin alone and a depot injection are not combined products, and emergency contraception is furnished under the separate protocol in 16 CCR section 1746.
4. Patient R.T. is picking up a new prescription at Sierra Valley Pharmacy. He says he is in a hurry and declines consultation. The pharmacist:
16 CCR section 1707.2(e) provides that a pharmacist “is not required to provide oral consultation when a patient or the patient's agent refuses such consultation”. The regulation does not require holding the drug, substituting a technician, or obtaining the prescriber's approval before dispensing. Consultation duties belong to the pharmacist and cannot be shifted to a technician.
5. Under 16 CCR 1715.65, how often must a pharmacy prepare an inventory reconciliation report for federal Schedule II controlled substances?
16 CCR 1715.65(a)(1) requires reports for federal Schedule II controlled substances “at least once every three months” (rule as of January 1, 2027). The 12-month cycle applies only to the products listed in subdivision (a)(2), and other controlled substances need inventory activities at least once every two years under (a)(3)(B). Monthly and six-month cycles do not appear in the section.
6. A pharmacist at Riverton Pharmacy suspects that a patient's serious reaction was caused by a marketed drug. Which action is the MOST appropriate?
Suspected serious adverse events from marketed drugs are reported to the FDA's MedWatch program, which collects such reports from health professionals. Waiting for a recurrence delays the signal. An insurance carrier is not a safety-reporting channel, and the Board of Pharmacy's medication error rules in 16 CCR section 1711 concern errors in dispensing, not drug reactions.
7. Lakeview Pharmacy dispenses a Schedule II prescription and prepares the report to CURES required by Health and Safety Code section 11165(d). Which of the following must be included in the report?
Section 11165(d)(4) lists the National Drug Code (NDC) number of the controlled substance dispensed among the required report data, together with the patient's name, address, gender and date of birth, the quantity dispensed, the number of refills and the prescribing and dispensing dates. The list in section 11165(d) does not include a Social Security number, an insurance member number or the type of identification the patient showed.